Pacific Biosciences of California Inc
PACB1.315USD
-0.015-1.13%
交易中 （美东）报价延迟15分钟
394.55M总市值
亏损市盈率 TTM
关于 Pacific Biosciences of California Inc 公司
Pacific Biosciences of California, Inc. 是一家生命科学技术公司。该公司致力于设计、开发和制造先进的测序解决方案，帮助科学家和临床研究人员解决复杂的遗传问题。该公司正在开发的产品和技术源自两项差异化的核心技术，包括其 HiFi 长读测序技术和结合测序 (SBB) 短读测序技术。该公司的产品为一系列应用提供解决方案，包括人类遗传学、植物和动物科学、传染病和微生物学、肿瘤学和其他新兴应用。该公司开发了基于单分子实时技术的 HiFi 长读测序，可准确检测单个 DNA 分子的核苷酸序列和表观遗传状态。其 Revio、Sequel、Sequel II 和 Sequel IIe 仪器可实时进行、监测和分析单分子生化反应。
公司简介
公司代码PACB
公司名称Pacific Biosciences of California Inc
上市日期Oct 27, 2010
CEOMr. Christian O. Henry
员工数量575
证券类型Ordinary Share
年结日Oct 27
公司地址1305 O'brien Drive
城市MENLO PARK
上市交易所NASDAQ Global Select Consolidated
国家United States of America
邮编94025
电话16505218000
网址https://www.pacb.com/
公司代码PACB
上市日期Oct 27, 2010
CEOMr. Christian O. Henry
公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Christian O. Henry
Mr. Christian O. Henry
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
696.81K
-17.96%
Mr. Marshall L. Mohr, CPA
Mr. Marshall L. Mohr, CPA
Independent Director
Independent Director
110.00K
-17.18%
Dr. John F. Milligan, Ph.D.
Dr. John F. Milligan, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
110.00K
-17.18%
Mr. Randall S. (Randy) Livingston
Mr. Randall S. (Randy) Livingston
Independent Director
Independent Director
22.82K
--
Dr. Hannah A. Valantine, M.D.
Dr. Hannah A. Valantine, M.D.
Independent Director
Independent Director
--
--
Mr. Christopher M. (Chris) Smith
Mr. Christopher M. (Chris) Smith
Independent Director
Independent Director
--
--
Dr. Lucy Shapiro, Ph.D.
Dr. Lucy Shapiro, Ph.D.
Independent Director
Independent Director
--
-100.00%
Mr. Mark Van Oene
Mr. Mark Van Oene
Chief Operating Officer
Chief Operating Officer
--
--
Mr. Jim R. Gibson
Mr. Jim R. Gibson
Chief Financial Officer, Principal Financial Officer
Chief Financial Officer, Principal Financial Officer
--
--
Ms. Kathy P. Ordonez
Ms. Kathy P. Ordonez
Independent Director
Independent Director
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Christian O. Henry
Mr. Christian O. Henry
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
696.81K
-17.96%
Mr. Marshall L. Mohr, CPA
Mr. Marshall L. Mohr, CPA
Independent Director
Independent Director
110.00K
-17.18%
Dr. John F. Milligan, Ph.D.
Dr. John F. Milligan, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
110.00K
-17.18%
Mr. Randall S. (Randy) Livingston
Mr. Randall S. (Randy) Livingston
Independent Director
Independent Director
22.82K
--
Dr. Hannah A. Valantine, M.D.
Dr. Hannah A. Valantine, M.D.
Independent Director
Independent Director
--
--
Mr. Christopher M. (Chris) Smith
Mr. Christopher M. (Chris) Smith
Independent Director
Independent Director
--
--
收入明细
单位: USD更新时间: 7月6日 周日
单位: USD更新时间: 7月6日 周日
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
业务USD
名称
营收
占比
Consumable revenue
20.10M
54.09%
Instrument revenue
11.02M
29.65%
Service And Other
6.04M
16.26%
地区USD
名称
营收
占比
North America
16.30M
43.88%
Asia Pacific
11.61M
31.25%
Europe (including the Middle East and Africa)
9.24M
24.87%
业务
地区
业务USD
名称
营收
占比
Consumable revenue
20.10M
54.09%
Instrument revenue
11.02M
29.65%
Service And Other
6.04M
16.26%
股东统计
更新时间: 6月13日 周五
更新时间: 6月13日 周五
持股股东
股东类型
持股股东
持股股东
占比
ARK Investment Management LLC
12.10%
Madrone Advisors, LLC
7.80%
SoftBank Group Corp
6.82%
BlackRock Institutional Trust Company, N.A.
6.81%
The Vanguard Group, Inc.
5.40%
Other
61.08%
持股股东
持股股东
占比
ARK Investment Management LLC
12.10%
Madrone Advisors, LLC
7.80%
SoftBank Group Corp
6.82%
BlackRock Institutional Trust Company, N.A.
6.81%
The Vanguard Group, Inc.
5.40%
Other
61.08%
股东类型
持股股东
占比
Investment Advisor
46.28%
Investment Advisor/Hedge Fund
11.14%
Holding Company
6.82%
Research Firm
2.18%
Hedge Fund
2.07%
Individual Investor
1.18%
Corporation
1.17%
Bank and Trust
0.50%
Pension Fund
0.26%
Other
28.40%
机构持股
更新时间: 7月1日 周二
更新时间: 7月1日 周二
报告期
机构数
持股数
持股占比
持股变动
2025Q2
600
215.28M
71.74%
-113.79M
2025Q1
629
227.30M
75.82%
-104.21M
2024Q4
625
258.31M
94.32%
-61.55M
2024Q3
618
231.32M
84.94%
-85.30M
2024Q2
629
240.26M
88.29%
-64.03M
2024Q1
637
265.38M
97.57%
-38.04M
2023Q4
643
276.71M
103.53%
-9.49M
2023Q3
631
258.82M
103.48%
-18.47M
2023Q2
639
248.61M
99.68%
-37.06M
2023Q1
649
249.45M
101.17%
-6.40M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
ARK Investment Management LLC
36.48M
12.16%
+434.08K
+1.20%
Mar 31, 2025
Madrone Advisors, LLC
23.39M
7.8%
--
--
Mar 31, 2025
SoftBank Group Corp
20.45M
6.82%
--
--
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
20.44M
6.81%
-1.17M
-5.42%
Mar 31, 2025
The Vanguard Group, Inc.
16.21M
5.4%
+1.04M
+6.83%
Mar 31, 2025
Edmond de Rothschild Asset Management (France) S.A.
21.86M
7.28%
+508.70K
+2.38%
Mar 31, 2025
Nikko Asset Management Co., Ltd.
9.57M
3.19%
-613.17K
-6.02%
Mar 31, 2025
State Street Global Advisors (US)
6.38M
2.13%
-47.38K
-0.74%
Mar 31, 2025
Geode Capital Management, L.L.C.
6.32M
2.11%
+54.32K
+0.87%
Mar 31, 2025
T. Rowe Price Investment Management, Inc.
4.89M
1.63%
-8.23K
-0.17%
Mar 31, 2025
查看更多
持股ETF
更新时间: 8月2日 周六
更新时间: 8月2日 周六
机构名称
占比
ARK Genomic Revolution ETF
1.34%
iShares Genomics Immunology and Healthcare ETF
0.75%
Invesco NASDAQ Future Gen 200 ETF
0.58%
Global X Genomics & Biotechnology ETF
0.42%
ARK Innovation ETF
0.41%
WisdomTree BioRevolution Fund
0.31%
AXS Green Alpha ETF
0.27%
Invesco Nasdaq Biotechnology ETF
0.04%
ProShares Ultra Nasdaq Biotechnology
0.04%
Invesco RAFI US 1500 Small-Mid ETF
0.04%
查看更多
ARK Genomic Revolution ETF
占比1.34%
iShares Genomics Immunology and Healthcare ETF
占比0.75%
Invesco NASDAQ Future Gen 200 ETF
占比0.58%
Global X Genomics & Biotechnology ETF
占比0.42%
ARK Innovation ETF
占比0.41%
WisdomTree BioRevolution Fund
占比0.31%
AXS Green Alpha ETF
占比0.27%
Invesco Nasdaq Biotechnology ETF
占比0.04%
ProShares Ultra Nasdaq Biotechnology
占比0.04%
Invesco RAFI US 1500 Small-Mid ETF
占比0.04%
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
